DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sphere of biopharmaceuticals, providing promising enhancements throughout several healthcare and industrial apps. With its structural similarity to Obviously derived human serum albumin, OsrHSA presents a safer, much more dependable alternate for therapeutic use, part